AI-Generated Off-Label Claims: What Pharma Needs to Know Before the FDA Calls
The Problem No One Is Watching Closely Enough Somewhere between a patient typing symptoms into a chatbot and a physician […]
How to Build an AI Monitoring Dashboard for Drug Brands Before a Chatbot Hurts You
Patients are asking ChatGPT about your drug. Physicians are consulting Gemini before prescribing. Regulators are building their own AI review
AI Is Talking About Your Drug. Your Brand Team Isn’t Listening.
How ChatGPT, Gemini, and a dozen other AI chatbots became the most unmonitored channel in pharmaceutical brand strategy — and
Increase Pharma Brand Equity by Monitoring AI Conversations
The medical information landscape has shifted from static search results to dynamic, generative responses. While pharmaceutical companies have spent decades
